Drug:
Reaction: OVERDOSE
20250101 - 20251231
No. 2101 - 2200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 2101 | 25395923 |
JP |
69 | 2 |
Overdose, Toxicity to various agents, Circulatory collapse, Altered state of consciousness, |
||||
AMLODIPINE BESYLATE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
| 2102 | 25396379 |
HR |
1 | |
Somnolence, Suicide attempt, Alcohol abuse, Drug abuse, Overdose, |
||||
PREGABALIN, ALPRAZOLAM, BUPROPION HYDROCHLORIDE, ALPRAZOLAM, |
||||
| 2103 | 25396462 |
US |
2 | |
Overdose, Drug dependence, Emotional distress, Pain, |
||||
BUPRENORPHINE, HYDROCODONE BITARTRATE AND ACETAMINOPHEN, |
||||
| 2104 | 25397127 |
US |
3 | 2 |
Overdose, Contraindicated product administered, |
||||
NALTREXONE, |
||||
| 2105 | 25397714 |
US |
82 | 2 |
Application site pruritus, Overdose, Intentional product use issue, |
||||
MINOXIDIL, |
||||
| 2106 | 25397828 |
US |
2 | |
Hair growth abnormal, Inappropriate schedule of product administration, Overdose, |
||||
MINOXIDIL, |
||||
| 2107 | 25397890 |
US |
2 | |
Rash, Intentional product use issue, Inappropriate schedule of product administration, Overdose, Product administered at inappropriate site, |
||||
MINOXIDIL, MINOXIDIL, MINOXIDIL, MINOXIDIL, |
||||
| 2108 | 25397929 |
US |
2 | |
Overdose, Product administered at inappropriate site, Intentional product use issue, |
||||
MINOXIDIL, |
||||
| 2109 | 25398092 |
US |
30 | 2 |
Incorrect dose administered, Overdose, Inappropriate schedule of product administration, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 2110 | 25387946 |
AU |
61 | 2 |
Pyrexia, Alanine aminotransferase increased, Overdose, |
||||
TRASTUZUMAB, PEMBROLIZUMAB, CAPECITABINE, TUCATINIB, TUCATINIB, |
||||
| 2111 | 25388173 |
US |
||
Overdose, Toxicity to various agents, Acute kidney injury, Distributive shock, Sepsis, Schizophrenia, Hypotension, Tachycardia, |
||||
AMLODIPINE, LISINOPRIL, |
||||
| 2112 | 25388658 |
IN |
14 | 2 |
Delirium, Hallucination, Mydriasis, Condition aggravated, Overdose, Product use in unapproved indication, |
||||
RANITIDINE, RANITIDINE, |
||||
| 2113 | 25388838 |
US |
60 | 2 |
Feeling abnormal, Nausea, Vomiting, Overdose, Underdose, Intentional product use issue, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TADALAFIL, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, AMBRISENTAN, FUROSEMIDE, ALBUTEROL SULFATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LOSARTAN POTASSIUM, LOSARTAN, MACITENTAN, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, MUPIROCIN, MUPIROCIN CALCIUM, |
||||
| 2114 | 25389063 |
US |
37 | 2 |
Overdose, |
||||
FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE CHEWABLE TABLET, FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE, |
||||
| 2115 | 25389155 |
CA |
2 | |
Maternal exposure during pregnancy, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Immunodeficiency, Infusion related reaction, Intentional product misuse, Joint swelling, Off label use, Overdose, Pain, Prescribed overdose, Product use issue, |
||||
TOCILIZUMAB, TOCILIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 2116 | 25389246 |
US |
||
Overdose, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 2117 | 25389247 |
CA |
||
Ingrown hair, Blood iron decreased, Infection, Inflammatory marker increased, Haemoglobin decreased, Intentional product use issue, Overdose, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 2118 | 25389554 |
AU |
||
Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2119 | 25389899 |
US |
37 | 2 |
Overdose, Toxicity to various agents, Product use in unapproved indication, |
||||
FENTANYL, AMPHETAMINE, MORPHINE, DRONABINOL, |
||||
| 2120 | 25389927 |
US |
26 | 1 |
Basal ganglia infarction, Hypoxia, Overdose, Muscular weakness, |
||||
FENTANYL, |
||||
| 2121 | 25390249 |
FR |
57 | 2 |
Cardiogenic shock, Poisoning, Overdose, |
||||
BISOPROLOL FUMARATE, ALPRAZOLAM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, DAPAGLIFLOZIN, |
||||
| 2122 | 25390275 |
CN |
14 | 1 |
Overdose, Vomiting, Drug level increased, |
||||
METHOTREXATE SODIUM, METHOTREXATE SODIUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 2123 | 25390564 |
AU |
||
Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2124 | 25390769 |
US |
65 | 2 |
Loss of consciousness, Diarrhoea, Overdose, Nausea, Underdose, Feeling abnormal, Headache, Muscle spasms, Vomiting, Tremor, Heart rate increased, Vision blurred, Disturbance in attention, Migraine with aura, Alopecia, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, |
||||
| 2125 | 25391479 |
CN |
53 | 2 |
Overdose, Toxicity to various agents, Medication error, |
||||
LINAGLIPTIN, |
||||
| 2126 | 25391489 |
US |
1 | |
Overdose, Drug dependence, |
||||
OXYCODONE HYDROCHLORIDE, |
||||
| 2127 | 25391499 |
CN |
69 | 2 |
Depressed level of consciousness, Pyrexia, Miosis, Overdose, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 2128 | 25391720 |
US |
1 | |
Overdose, Drug ineffective, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
| 2129 | 25391785 |
DE |
63 | 2 |
Thrombotic microangiopathy, Toxicity to various agents, Drug-induced liver injury, Metabolic alkalosis, Hypovolaemia, Hypokalaemia, Respiratory alkalosis, Sinus tachycardia, Dyspnoea, Skin discolouration, Muscular weakness, Drug interaction, Skin haemorrhage, Acute hepatic failure, Hepatic cirrhosis, Overdose, Hypoalbuminaemia, Haemochromatosis, Pneumonia influenzal, Haemolytic anaemia, Acute kidney injury, Anaemia folate deficiency, Escherichia urinary tract infection, Nephrotic syndrome, Pulmonary oedema, Hepatosplenomegaly, Coagulopathy, Drug-induced liver injury, Ascites, Acute kidney injury, Oedema peripheral, Coombs negative haemolytic anaemia, Thrombocytopenia, Immunosuppressant drug level increased, Petechiae, Erythema, Oliguria, Anaemia, |
||||
LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, FUROSEMIDE, IRON, PANTOPRAZOLE, PANTOPRAZOLE, SIMVASTATIN, SIMVASTATIN, |
||||
| 2130 | 25382751 |
CN |
56 | 1 |
Acute kidney injury, Chest discomfort, Mucosal membrane hyperplasia, Nausea, Vomiting, Overdose, Gastric ulcer, Chronic gastritis, Urine output decreased, Oedema, Erosive oesophagitis, Oesophageal ulcer, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 2131 | 25382827 |
US |
1 | |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2132 | 25382860 |
US |
1 | |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2133 | 25382862 |
US |
1 | |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2134 | 25382892 |
US |
1 | |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2135 | 25382900 |
US |
1 | |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2136 | 25382903 |
US |
1 | |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2137 | 25382909 |
US |
1 | |
Shock, Overdose, Toxicity to various agents, |
||||
LISINOPRIL, AMLODIPINE, |
||||
| 2138 | 25382912 |
US |
2 | |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2139 | 25382918 |
US |
2 | |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2140 | 25382925 |
US |
2 | |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2141 | 25382928 |
US |
2 | |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2142 | 25382932 |
US |
2 | |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2143 | 25382938 |
US |
2 | |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2144 | 25382950 |
US |
2 | |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2145 | 25383164 |
US |
64 | 2 |
Incorrect dose administered by device, Drug dose omission by device, Overdose, Device delivery system issue, Product cleaning inadequate, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, |
||||
| 2146 | 25383469 |
US |
13 | 2 |
Cardiac dysfunction, Acute kidney injury, Metabolic disorder, Multiple organ dysfunction syndrome, Sinus tachycardia, Electrocardiogram QT prolonged, Abdominal tenderness, Tachypnoea, Mental status changes, Troponin increased, Brain natriuretic peptide increased, Ischaemia, Aspartate aminotransferase increased, Alanine aminotransferase increased, Cardiomyopathy, Lipase increased, Coronary artery dilatation, Suicide attempt, Pancreatitis, Hypotension, Liver function test increased, Metabolic acidosis, Hyperlactacidaemia, Acidosis, Nausea, Vomiting, Abdominal pain, Hypothermia, Overdose, Toxicity to various agents, Product administration error, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ENALAPRIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SERTRALINE, |
||||
| 2147 | 25383626 |
US |
2 | |
Alopecia, Product use issue, Intentional product misuse, Overdose, |
||||
| 2148 | 25383914 |
US |
50 | 1 |
Inappropriate schedule of product administration, Headache, Overdose, |
||||
| 2149 | 25384173 |
US |
||
Ventricular dysfunction, Acute kidney injury, Pancreatitis, Cardiotoxicity, Toxicity to various agents, Metabolic acidosis, Hyperlactacidaemia, Overdose, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SERTRALINE, |
||||
| 2150 | 25384701 |
JP |
49 | 2 |
Serum ferritin increased, Product use issue, Hypophosphataemic osteomalacia, Overdose, |
||||
FERRIC DERISOMALTOSE, |
||||
| 2151 | 25384736 |
US |
16 | 1 |
Overdose, Device delivery system issue, Product deposit, |
||||
SOMATROPIN, SOMATROPIN, SOMATROPIN, |
||||
| 2152 | 25384981 |
FR |
75 | 1 |
Renal tubular necrosis, Acute kidney injury, Overdose, |
||||
VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, |
||||
| 2153 | 25385600 |
US |
13 | 2 |
Metabolic acidosis, Hyperlactacidaemia, Acute kidney injury, Cardiac dysfunction, Lactic acidosis, Ventricular dysfunction, Pancreatitis, Hypothermia, Electrocardiogram QT prolonged, Aspartate aminotransferase increased, Alanine aminotransferase increased, Suicide attempt, Intentional overdose, Overdose, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SERTRALINE, |
||||
| 2154 | 25385674 |
US |
51 | 2 |
Sciatica, Pain, Insomnia, Nocturia, Diarrhoea, Illness, Gastroenteritis viral, Product dose omission issue, Overdose, |
||||
TOLVAPTAN, TOLVAPTAN, TOLVAPTAN, TOLVAPTAN, TIRZEPATIDE, |
||||
| 2155 | 25385755 |
US |
||
Unresponsive to stimuli, Overdose, Device defective, Device malfunction, Manufacturing issue, Recalled product, Recalled product administered, |
||||
FENTANYL, |
||||
| 2156 | 25386483 |
EU |
41 | 1 |
Drug ineffective, Drug resistance, Condition aggravated, Psychotic symptom, Apathy, Depressed mood, Anxiety, Multiple-drug resistance, Negative thoughts, Overdose, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, HALOPERIDOL, HALOPERIDOL LACTATE, VALPROIC ACID, VALPROIC ACID, VALPROIC ACID, VALPROIC ACID, HYDROXYZINE, HYDROXYZINE, HYDROXYZINE, HYDROXYZINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 2157 | 25386765 |
US |
77 | 1 |
Overdose, Product administered at inappropriate site, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2158 | 25386827 |
US |
38 | 1 |
Gastrooesophageal reflux disease, Overdose, Inappropriate schedule of product administration, |
||||
OMEPRAZOLE MAGNESIUM, OMEPRAZOLE MAGNESIUM, |
||||
| 2159 | 25386829 |
US |
||
Overdose, |
||||
OMEPRAZOLE MAGNESIUM, |
||||
| 2160 | 25386929 |
US |
||
Overdose, Drug dependence, Emotional distress, Pain, |
||||
OXYCODONE HYDROCHLORIDE, BUPRENORPHINE, |
||||
| 2161 | 25387265 |
US |
15 | |
Suicide attempt, Overdose, |
||||
INSULIN LISPRO, |
||||
| 2162 | 25387324 |
US |
2 | |
Seizure, Cerebrovascular accident, Laryngeal dyskinesia, Dyskinesia, Swollen tongue, Asthenia, Oropharyngeal pain, Overdose, Off label use, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 2163 | 25381555 |
IT |
||
Cytokine release syndrome, Overdose, |
||||
TRASTUZUMAB, |
||||
| 2164 | 25381650 |
BE |
||
Drug-induced liver injury, Psoriasis, Arthritis, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 2165 | 25381901 |
US |
13 | 2 |
Metabolic acidosis, Hyperlactacidaemia, Acute kidney injury, Cardiac dysfunction, Overdose, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 2166 | 25382034 |
GB |
57 | 1 |
Overdose, Hypoglycaemia, |
||||
DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2167 | 25382079 |
US |
13 | 2 |
Cardiac dysfunction, Acute kidney injury, Metabolic acidosis, Hyperlactacidaemia, Overdose, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 2168 | 25376519 |
EU |
74 | 1 |
Loss of consciousness, Overdose, Suicide attempt, |
||||
FOSCARBIDOPA/FOSLEVODOPA, PANTOPRAZOLE, |
||||
| 2169 | 25377005 |
HR |
||
Suicide attempt, Alcohol abuse, Drug abuse, Somnolence, Overdose, |
||||
BUPROPION HYDROCHLORIDE, PREGABALIN, ALPRAZOLAM, ALPRAZOLAM, |
||||
| 2170 | 25377113 |
US |
28 | 2 |
Generalised tonic-clonic seizure, Choking, Poor quality sleep, Wheezing, Overdose, |
||||
LACOSAMIDE, CLOBAZAM, CANNABIDIOL, |
||||
| 2171 | 25377355 |
US |
2 | |
Seizure, Drop attacks, Partial seizures, Atonic seizures, Hypotension, Fall, Injury, Syncope, Loss of consciousness, Tooth abscess, Dizziness postural, Electrocardiogram ambulatory, Dizziness, Tooth avulsion, Skin laceration, Drug ineffective, Overdose, |
||||
FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, FENFLURAMINE, LEVETIRACETAM, DIAZEPAM, CLONAZEPAM, CLOBAZAM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, FOLIC ACID, NORETHINDRONE ACETATE, NORETHINDRONE, LEVOTHYROXINE, ERGOCALCIFEROL, ERGOCALCIFEROL, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, ETONOGESTREL, SOMATROPIN, |
||||
| 2172 | 25379062 |
US |
16 | 2 |
Gait disturbance, Suicidal ideation, Therapy partial responder, Overdose, |
||||
BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, OLANZAPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, CLONAZEPAM, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, LISINOPRIL, DULOXETINE HYDROCHLORIDE, DULOXETINE, BUPROPION, BUPROPION, BUPROPION, |
||||
| 2173 | 25379093 |
FR |
||
Rash, Face oedema, Oedema peripheral, Overdose, |
||||
RITUXIMAB-ABBS, ALLOPURINOL, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, |
||||
| 2174 | 25379378 |
DE |
42 | 2 |
Overdose, Shock, Multiple organ dysfunction syndrome, Sinus tachycardia, Rhabdomyolysis, Acute kidney injury, Transaminases increased, Coagulopathy, Antidepressant drug level, Product residue present, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 2175 | 25379413 |
US |
35 | 1 |
Condition aggravated, Sinus tachycardia, Pulmonary alveolar haemorrhage, Respiratory distress, Tachypnoea, Haemoptysis, Respiratory failure, Substance abuse, Respiratory failure, Overdose, |
||||
BUPROPION, |
||||
| 2176 | 25379785 |
US |
33 | 1 |
Toxicity to various agents, Overdose, |
||||
FENTANYL, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), GABAPENTIN, |
||||
| 2177 | 25379995 |
32 | 1 | |
Vomiting, Overdose, Fall, Tremor, Withdrawal syndrome, |
||||
| 2178 | 25380963 |
US |
42 | 2 |
Seizure, Product availability issue, Therapy interrupted, Incorrect dose administered, Overdose, Inability to afford medication, |
||||
BRIVARACETAM, BRIVARACETAM, |
||||
| 2179 | 25381085 |
CA |
33 | 1 |
Diarrhoea haemorrhagic, Constipation, Loss of employment, Dysarthria, Tremor, Overdose, Skin discolouration, Gastrointestinal pain, Alopecia, Tinnitus, Discomfort, Flatulence, Cerebral disorder, Feeling abnormal, |
||||
NAPROXEN, NAPROXEN SODIUM, |
||||
| 2180 | 25381516 |
US |
60 | 2 |
Haemoglobin increased, Overdose, |
||||
TADALAFIL, TREPROSTINIL, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, AMBRISENTAN, FUROSEMIDE, ALBUTEROL SULFATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LOSARTAN POTASSIUM, LOSARTAN, MACITENTAN, SOTATERCEPT-CSRK, MUPIROCIN, MUPIROCIN CALCIUM, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, |
||||
| 2181 | 25371306 |
US |
2 | |
Blood glucose increased, Overdose, Inappropriate schedule of product administration, Product storage error, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, EMPAGLIFLOZIN, |
||||
| 2182 | 25371376 |
US |
68 | 2 |
Overdose, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 2183 | 25371384 |
US |
47 | 1 |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2184 | 25371385 |
US |
23 | 2 |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2185 | 25371386 |
US |
22 | 2 |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2186 | 25371389 |
US |
20 | 2 |
Serotonin syndrome, Rhabdomyolysis, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2187 | 25371390 |
US |
38 | 2 |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2188 | 25371494 |
US |
21 | 2 |
Serotonin syndrome, Overdose, |
||||
BUPROPION HYDROCHLORIDE, |
||||
| 2189 | 25371580 |
AU |
||
Suicide attempt, Acute hepatic failure, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2190 | 25371853 |
AU |
||
Pneumonia aspiration, Electrocardiogram QRS complex prolonged, Dysarthria, Bundle branch block right, Sinus tachycardia, Toxicity to various agents, Overdose, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 2191 | 25371956 |
AU |
||
Adenovirus infection, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LENALIDOMIDE, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LORATADINE, LORATADINE ORAL, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PENTAMIDINE ISETHIONATE, |
||||
| 2192 | 25372062 |
KR |
2 | |
Insomnia, Depression, Anxiety, Device dislocation, Complication of device removal, Complication associated with device, Abdominal discomfort, Hypomenorrhoea, Breast calcifications, Soft tissue foreign body, Overdose, Device issue, Device placement issue, Incorrect product administration duration, Incorrect product administration duration, |
||||
ETONOGESTREL, ETONOGESTREL, ETONOGESTREL, |
||||
| 2193 | 25372079 |
US |
1 | |
Overdose, |
||||
GUAIFENESIN, |
||||
| 2194 | 25372182 |
US |
79 | 2 |
Cough, Device difficult to use, Overdose, Inappropriate schedule of product administration, Product complaint, |
||||
FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, |
||||
| 2195 | 25372614 |
US |
51 | 1 |
Drug ineffective, Overdose, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 2196 | 25372847 |
US |
65 | 2 |
Overdose, Renal impairment, Drug ineffective, Acute kidney injury, |
||||
TOBRAMYCIN, TOBRAMYCIN SULFATE, TOBRAMYCIN SOLUTION, MEROPENEM, PREDNISONE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, EVEROLIMUS, EVEROLIMUS TABLETS, CEFEPIME HYDROCHLORIDE, CEFEPIME, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CYCLOSPORINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 2197 | 25372892 |
EU |
81 | 2 |
Upper airway obstruction, Freezing phenomenon, Anxiety, Fatigue, Withdrawal syndrome, Chest discomfort, Dyspnoea, Initial insomnia, Joint stiffness, Throat irritation, Dysphagia, Overdose, Product use issue, Product prescribing error, Wrong technique in product usage process, Drug ineffective, |
||||
MELATONIN, OXAZEPAM, RASAGILINE MESYLATE, ROTIGOTINE, CARBIDOPA AND LEVODOPA, OXAZEPAM, |
||||
| 2198 | 25373237 |
EU |
92 | 2 |
Atrioventricular block, Overdose, Bradycardia, |
||||
BISOPROLOL FUMARATE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, LACTULOSE, FUROSEMIDE, FOLIC ACID, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2199 | 25373245 |
US |
2 | |
Hair growth abnormal, Overdose, |
||||
| 2200 | 25373530 |
US |
66 | 1 |
Somnolence, Miosis, Rhinorrhoea, Sinus bradycardia, Hypertension, Sedation complication, Mental status changes, Diastolic dysfunction, Overdose, Dizziness, |
||||
DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, QUININE SULFATE, QUININE, FENTANYL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30